Explore the vast range of titles available.

Density estimates accounting for differential animal detectability are difficult to acquire for wide-ranging and elusive species such as mammalian carnivores. Pairing distance sampling with call-response surveys may provide an efficient means of tracking changes in populations of coyotes (Canis latrans), a species of particular interest in the eastern United States. Blind field trials in rural New York State indicated 119-m linear error for triangulated coyote calls, and a 1.8-km distance threshold for call detectability, which was sufficient to estimate a detection function with precision using distance sampling. We conducted statewide road-based surveys with sampling locations spaced ≥6 km apart from June to August 2010. Each detected call (be it a single or group) counted as a single object, representing 1 territorial pair, because of uncertainty in the number of vocalizing animals. From 524 survey points and 75 detections, we estimated the probability of detecting a calling coyote to be 0.17 ± 0.02 SE, yielding a detection-corrected index of 0.75 pairs/10 km2 (95% CI: 0.52–1.1, 18.5% CV) for a minimum of 8,133 pairs across rural New York State. Importantly, we consider this an index rather than true estimate of abundance given the unknown probability of coyote availability for detection during our surveys. Even so, pairing distance sampling with call-response surveys provided a novel, efficient, and noninvasive means of monitoring populations of wide-ranging and elusive, albeit reliably vocal, mammalian carnivores. Our approach offers an effective new means of tracking species like coyotes, one that is readily extendable to other species and geographic extents, provided key assumptions of distance sampling are met. © 2015 The Wildlife Society.

Estimating the abundance of wide-ranging wildlife, difficult under any circumstances, is particularly challenging when detection is low and affected by factors that also influence density and distribution. In northeastern Washington, moose (Alces alces) have evidently increased since the 1970s but spend most of their time under coniferous cover that makes detection from the air difficult. We used a Bayesian hierarchical approach to incorporate habitat use (in the form of availability as a function of canopy closure) into a detection model within a mark-recapture distance sampling framework to estimate moose density. Our model of availability used a latent density surface employing habitat use data obtained from 17 adult female moose wearing global positioning system (GPS) collars. Distance sampling data, obtained from helicopter surveys in winters 2014, 2015, and 2016, consisted of double-observer detections of 166 moose groups along 2,241 km of systematically placed line transects within 29 survey blocks selected using a stratified-random design. We estimated moose density over the entire survey area as 0.49/km² (95% credible interval = 0.33–0.67/km²). Extrapolated to the 10,513-km² survey area, we estimated 5,169 moose (95% credible interval = 3,510–7,034). Our methodology allowed us to adjust for availability bias and produce an estimate even where detection was difficult but required many hours of helicopter flights, acceptable weather conditions, and the availability of GPS collared-moose.

With an appropriate prescription, the use of a lower limb prosthesis can help mitigate mobility limitations and increased risk of falling for people with lower limb amputation. Prosthetic feet cannot replicate all the functions of a biological foot-ankle. Different feet have different designs and properties, and therefore there are functional trade-offs. There is insufficient evidence as to the effects these different prosthetic foot properties have on users' stability and balance, which would be helpful to guide clinical prosthesis prescription. Prosthesis users also rarely have opportunities to try walking with different prosthetic feet to give experiential input during the prescription process. Therefore, this study aims to determine 1) the effects of prosthetic foot stiffness on stability in lower limb prosthesis users while walking on varying terrains, and 2) whether a brief 'test-drive' strategy for selecting prosthetic feet can be used to predict longer term stability, balance confidence, and foot preference outcomes in lower limb prosthesis users. In this multisite, participant-masked, randomized cross-over study, participants with unilateral, transtibial amputation will walk on different treadmill conditions (flat, incline, cross-slopes, uneven ground) with a variety of commercially-available prosthetic feet ('actual') and corresponding 'emulated' prosthetic feet in the laboratory. Participants will also wear the actual prosthetic feet at home and in the community for one week at a time. After each community trial, participants will return to the laboratory to complete walking trials on different terrains and at a range of speeds while we collect kinematic data. We will assess the effect of prosthetic foot stiffness on biomechanical and self-reported measures of stability. We will also assess how well brief 'test-drive' trials of walking with different prosthetic feet can predict longer-term self-reported measures of stability, balance confidence and preference. This study was prospectively registered at www.clinicaltrials.gov (Clinical Trials Study ID: NCT05473065). Study start date: March 1, 2024.

Approximately 476,000 cases of Lyme disease are diagnosed in the United States annually, yet comprehensive economic evaluations are lacking. In a prospective study among reported cases in Lyme disease-endemic states, we estimated the total patient cost and total societal cost of the disease. In addition, we evaluated disease and demographic factors associated with total societal cost. Participants had a mean patient cost of ≈$1,200 (median $240) and a mean societal cost of ≈$2,000 (median $700). Patients with confirmed disseminated disease or probable disease had approximately double the societal cost of those with confirmed localized disease. The annual, aggregate cost of diagnosed Lyme disease could be $345-968 million (2016 US dollars) to US society. Our findings emphasize the importance of effective prevention and early diagnosis to reduce illness and associated costs. These results can be used in cost-effectiveness analyses of current and future prevention methods, such as a vaccine.

Arctic and alpine tundra ecosystems are large reservoirs of organic carbon 1 , 2 . Climate warming may stimulate ecosystem respiration and release carbon into the atmosphere 3 , 4 . The magnitude and persistency of this stimulation and the environmental mechanisms that drive its variation remain uncertain 5 – 7 . This hampers the accuracy of global land carbon–climate feedback projections 7 , 8 . Here we synthesize 136 datasets from 56 open-top chamber in situ warming experiments located at 28 arctic and alpine tundra sites which have been running for less than 1 year up to 25 years. We show that a mean rise of 1.4 °C [confidence interval (CI) 0.9–2.0 °C] in air and 0.4 °C [CI 0.2–0.7 °C] in soil temperature results in an increase in growing season ecosystem respiration by 30% [CI 22–38%] ( n  = 136). Our findings indicate that the stimulation of ecosystem respiration was due to increases in both plant-related and microbial respiration ( n  = 9) and continued for at least 25 years ( n  = 136). The magnitude of the warming effects on respiration was driven by variation in warming-induced changes in local soil conditions, that is, changes in total nitrogen concentration and pH and by context-dependent spatial variation in these conditions, in particular total nitrogen concentration and the carbon:nitrogen ratio. Tundra sites with stronger nitrogen limitations and sites in which warming had stimulated plant and microbial nutrient turnover seemed particularly sensitive in their respiration response to warming. The results highlight the importance of local soil conditions and warming-induced changes therein for future climatic impacts on respiration. Datasets from in situ warming experiments across 28 arctic and alpine tundra sites covering  a span of less than 1 year up to 25 years show the importance of local soil conditions and warming-induced changes therein for future climatic impacts on ecosystem respiration.

Impaired gut barrier function may lead to progression of liver fibrosis in people with alcohol-related liver disease. The postbiotic ReFerm® can lower gut barrier permeability and may thereby  reduce fibrosis formation. Here, we report the results from an open-labelled, single centre randomized controlled trial where 56 patients with advanced, compensated, alcohol-related liver disease were assigned 1:1 to receive either ReFerm® ( n  = 28) or standard nutritional support (Fresubin®, n  = 28) for 24 weeks. The primary outcome was a ≥ 10% reduction of the fibrosis formation marker alpha-smooth muscle actin in liver biopsies, assessed by a blinded pathologist using automated digital imaging analysis. Paired liver biopsies meeting quality criteria for the primary outcome were available for 40 participants (ReFerm®, n  = 21 and Fresubin®, n  = 19). This reduction was observed in 29% of patients receiving ReFerm®, compared to 14% with Fresubin® (OR = 2.40; 95% CI 0.63 to 9.16; p  = 0.200). No treatment-related serious adverse events occurred. Our findings suggest that ReFerm® may reduce liver fibrosis by enhancing gut barrier function, potentially preventing the progression of alcohol-related liver disease. Impaired gut barrier function is a central driver of alcohol-related liver disease. This study indicates that the postbiotic ReFerm® improves gut barrier function and reduce liver stiffness and liver fibrosis, suggesting the gut barrier function as a potential treatment target.

Delay discounting (DD) is the choice of a smaller immediate reward over a larger delayed reward, which has been associated with a number of maladaptive behaviors. Episodic future thinking (EFT), the ability to project oneself into the future, is an intervention designed to reduce DD. EFT has reliable effects on DD, but the size of the effect varies, which could be due in part to the use of different control groups. Episodic recent thinking (ERT) serves as a common control for many EFT studies, but the temporal window of \"recent\" cues ranges from 24 hours ago to 12 days past. Since prior research has shown that retrospection can lead to prospection, it may be important to ensure that EFT controls do not inadvertently lead to prospection for some participants thereby increasing the variability of the control condition. The present study sought to develop a comparison group that standardizes the time frame and experiences that are the basis for the recent thinking control. Participants (n = 53, 18-45) were randomized to one of three conditions: EFT, ERT, or standardized episodic thinking (SET). Participants attended a laboratory appointment where they played mobile application games, created cues, and completed a DD task. There was a significant difference between groups (p<0.05), with EFT reducing discounting more than either control (p<0.05), and no differences between ERT and SET (p>0.05). This study established that SET provides an alternative control in EFT studies and provides the advantage of standardizing the participant's recent experience without changing the relationship between EFT and recent thinking controls.

Xylan is a major component of the plant cell wall and the most abundant noncellulosic component in the secondary cell walls that constitute the largest part of plant biomass. Dicot glucuronoxylan consists of a linear backbone of β(1,4)-linked xylose residues substituted with α(1,2)-linked glucuronic acid (GlcA). Although several genes have been implicated in xylan synthesis through mutant analyses, the biochemical mechanisms responsible for synthesizing xylan are largely unknown. Here, we show evidence for biochemical activity of GUX1 (for GlcA substitution of xylan 1), a member of Glycosyltransferase Family 8 in Arabidopsis (Arabidopsis thaliana) that is responsible for adding the glucuronosyl substitutions onto the xylan backbone. GUX1 has characteristics typical of Golgi-localized glycosyltransferases and a K m for UDP-GlcA of 165 μM. GUX1 strongly favors xylohexaose as an acceptor over shorter xylooligosaccharides, and with xylohexaose as an acceptor, GlcA is almost exclusively added to the fifth xylose residue from the nonreducing end. We also show that several related proteins, GUX2 to GUX5 and Plant Glycogenin-like Starch Initiation Protein6, are Golgi localized and that only two of these proteins, GUX2 and GUX4, have activity as xylan α-glucuronosyltransferases.

The relative abundance of Wnt receptors plays a crucial role in controlling Wnt signaling in tissue homeostasis and human disease. While the ubiquitin ligases that ubiquitylate Wnt receptors are well-characterized, the deubiquitylase that reverses these reactions remains unclear. Herein, we identify USP46, UAF1, and WDR20 (USP46 complex) as positive regulators of Wnt signaling in cultured human cells. We find that the USP46 complex is similarly required for Wnt signaling in Xenopus and zebrafish embryos. We demonstrate that Wnt signaling promotes the association between the USP46 complex and cell surface Wnt coreceptor, LRP6. Knockdown of USP46 decreases steady-state levels of LRP6 and increases the level of ubiquitylated LRP6. In contrast, overexpression of the USP46 complex blocks ubiquitylation of LRP6 by the ubiquitin ligases RNF43 and ZNFR3. Size exclusion chromatography studies suggest that the size of the USP46 cytoplasmic complex increases upon Wnt stimulation. Finally, we show that USP46 is essential for Wnt-dependent intestinal organoid viability, likely via its role in LRP6 receptor homeostasis. We propose a model in which the USP46 complex increases the steady-state level of cell surface LRP6 and facilitates the assembly of LRP6 into signalosomes via a pruning mechanism that removes sterically hindering ubiquitin chains. Wnt receptors are controlled by their ubiquitin-mediated proteolysis. The authors show that the USP46 deubiquitylase complex potentiates Wnt signaling in human cells, Xenopus , and zebrafish by inhibiting cell surface LRP6 degradation.

•64% of the sample indicated willingness to get a Lyme disease vaccine.•30% were uncertain about getting a Lyme disease vaccine; 7% were unwilling.•The uncertain were parents, were non-white, and had vaccine safety concerns.•Safety messaging should be delivered by clinicians, especially to uncertain groups.•More studies will be useful once Lyme disease vaccine parameters are available. Lyme disease incidence is increasing, despite current prevention options. New Lyme disease vaccine candidates are in development, however, investigation of the acceptability of a Lyme disease vaccine among potential consumers is needed prior to any vaccine coming to market. We conducted a population-based, cross-sectional study to estimate willingness to receive a potential Lyme disease vaccine and factors associated with willingness. The web-based survey was administered to a random sample of Connecticut, Maryland, Minnesota, and New York residents June–July 2018. Survey-weighted descriptive statistics were conducted to estimate the proportion willing to receive a potential Lyme disease vaccine. Multivariable multinomial logistic regression models were used to quantify the association of sociodemographic characteristics and Lyme disease vaccine attitudes with willingness to be vaccinated. Surveys were completed by 3313 respondents (6% response rate). We estimated that 64% of residents were willing to receive a Lyme disease vaccine, while 30% were uncertain and 7% were unwilling. Compared to those who were willing, those who were uncertain were more likely to be parents, adults 45–65 years old, non-White, have less than a bachelor’s degree, or have safety concerns about a potential Lyme disease vaccine. Those who were unwilling were also more likely to be non-White, have less than a bachelor’s degree, or have safety concerns about a potential Lyme disease vaccine. In addition, the unwilling had low confidence in vaccines in general, had low perceived risk of contracting Lyme disease, and said they would not be influenced by a positive recommendation from a healthcare provider. Overall, willingness to receive a Lyme disease vaccine was high. Effective communication by clinicians regarding safety and other vaccine parameters to those groups who are uncertain will be critical for increasing vaccine uptake and reducing Lyme disease incidence.